TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

GH Research ( ($GHRS) ) has issued an update. GH Research PLC announced the presentation of data from its GH001-BD-202 clinical trial at the ...

Entera Bio (ENTX) announced data selected for presentation at the American Society for Bone and Mineral Research 2025 Annual Meeting in Seattle, ...

TG Therapeutics will present BRIUMVI® data on multiple sclerosis at the AAN 2025 annual meeting in San Diego.

Late-breaking oral presentation will highlight new data from a trial of INCA033989, an anti-mutant calreticulin (mutCALR)-directed monoclonal antibody, in patients with essential thrombocythemia ...

Boston— Allarity Therapeutics, Inc., a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib— a differentiated dual PARP/Wnt pathway inhibitor— announced the ...

JCR Pharmaceuticals announced the presentation of new data on lysosomal storage disorders at the SSIEM 2024 Annual Symposium.

Flatiron Health today announced their planned presence at this year’s San Antonio Breast Cancer Symposium (SABCS), including four accepted abstracts f ...

Ampligen has demonstrated data-driven promise in Progression-Free Survival and Overall Survival in both the DURIPANC clinical trial and an Early Access Program OCALA, Fla., Sept. 04, 2025 (GLOBE ...